3656 results for «310»
3656 results
TricValve - Addressing the unmet need for patients with right heart failure and functional tricuspid regurgitation - Real-life clinical outcomes
18 May 2022 – From EuroPCR 2022
Watch this EuroPCR 2022 session to learn all about the latest treatment option for patients with severe TR, to discover the supporting clinical evidence of TricValve, and to understand how the TricValve Transcatheter Bicaval Valves System can improve patient's quality of life.
Your most challenging TAVI cases - Achieving precision and control with Evolut platform
18 May 2022 – From EuroPCR 2022
How to deal with challenging anatomies? Find answers in this EuroPCR 2022 session with case studies to explore and learn how to achieve optimal patient outcomes with Evolut platform, uncover practical tips and techniques to achieve implant precision and control, and become familiar with technical considerations and procedural execution...
A new focus on mitral and tricuspid valve disease
18 May 2022 – From EuroPCR 2022
Find out more about the need for transcatheter replacement in the atrioventricular valves and the Intrepid programme, the potential of transvenous transseptal versus transapical access to the mitral valve, and the future of transvenous tricuspid valve replacement in this EuroPCR 2022 session.
Incorporating coronary orbital atherectomy to my practice
18 May 2022 – From EuroPCR 2022
This EuroPCR 2022 session aims to examine the improvement of technology in the treatment of highly calcified coronary lesions: get a practical perspective on how to integrate and perform orbital atherectomy in your clinical practice, become aware of its differential aspects compared to other plaque preparation...
Coronary microvascular dysfunction in case examples: invisible, measurable, treatable
18 May 2022 – From EuroPCR 2022
In this very practical session from EuroPCR 2022 focusing on microcirculation, learn how to perform a step-by-step assessment of the coronary microcirculation in the cathlab, discuss the whole management of patients with coronary microvascular dysfunction (CMD), and understand how to use coronary flow reserve (CFR) and index...
Is PCI enough in STEMI?
18 May 2022 – From EuroPCR 2022
With study results and case presentations, in this EuroPCR 2022 session, our experts try to demonstrate the need for improved outcomes in STEMI, and enable you to understand how infarct size and microvascular obstruction impact these outcomes, and to learn about SuperSaturated Oxygen Therapy and the data supporting infarct...
Nothing to fear - a guide to combine DCB and DES in hybrid PCI
19 May 2022 – From EuroPCR 2022
DCB in in-stent restenosis, DCB and DES, DCB in ACS, and a guide to use DCB in de novo lesions and bifurcations: this is the programme of this EuroPCR 2022 session devoted, not surprisingly, to drug-coated balloons.
Simplifying complex coronary interventions by adopting angiography-based physiology and a healing-targeted DES
19 May 2022 – From EuroPCR 2022
Consult this session to learn how to apply angio-based physiology to optimise patient selection for PCI, to discuss the impact of a healing-targeted DES on outcomes and DAPT duration, as well as to learn about the HT Supreme DES implantations in the (ongoing) QFR-guided, PIONEER IV trial.
SEISMIC-HF I - Exploring non-invasive methods for monitoring intracardiac filling pressures
16 Nov 2024
Luis Ortega provides his take on the SEISMIC-HF I study presented by Liviu Klein at AHA 2024, in Chicago.
Author
ECMO-CS – Extracorporeal membrane oxygenation in the therapy of cardiogenic shock: primary results from the multicenter, randomized ECMO-CS trial
07 Nov 2022
Mirvat Alasnag provides her take on the ECMO-CS trial, which was presented during AHA 2022 in Chicago, and simultaneously published in Circulation.
Author
The PRE18FFIR trial: Coronary Plaque Activity to Predict Recurrent Events
01 Sep 2022
Alex Sticchi provides his take on the PRE18FFIR trial: Prediction of recurrent events with 18F-Sodium Fluoride to identify ruptured and high-risk coronary artery plaques in patients with myocardial infarction.
Author
UNIVERSAL: routine ultrasonography guidance for femoral vascular access for cardiac procedures - A randomized clinical Trial
19 Sep 2022
Ali Nazmi Calik provides his take on UNIVERSAL randomized clinical trial, which questioned whether routine ultrasonography guidance for CFA access for cardiac procedures reduces bleeding or vascular complications. This trial was presented by Sanjit S. Jolly during TCT 2022.
Author
The 2023 ESH Hypertension Guidelines revisit the role of renal denervation
05 Sep 2023
The 2023 European Society of Hypertension (ESH) guidelines were recently presented at the 32nd annual European Meeting on Hypertension and Cardiovascular Protection and simultaneously published in the Journal of Hypertension.1 While wide parts of the guidelines do not substantially differ from the previous 2018 European Society...
Author
Author
Coronary OCT and CMR imaging to determine sex differences in underlying causes of myocardial infarction with no obstructive coronary arteries
29 Mar 2026
Nicola Ryan provides her take on the trial evaluating multi-modality imaging to determine underlying causes of MINOCA in women and men. The trial results were presented by Harmony R. Reynolds at ACC.26 in New Orleans and simultaneously published in Circulation.
Author
The AQUATIC trial: Assessment of quitting versus using aspirin therapy in patients with stabilized coronary artery disease after stenting who require long-term oral anticoagulation
01 Sep 2025
Chiara De Biase provides her take on the results of AQUATIC presented by Martine Gilard at ESC Congress 2025 in Madrid.
Author
![The AQUATIC trial [Assessment of quitting versus using aspirin therapy in patients with stabilized coronary artery disease after stenting who require long-term oral anticoagulation: Rationale for and design of the AQUATIC double-blind randomized trial]](https://www.pcronline.com/var/pcrov3/storage/images/pcronline/news/congress-coverages/esc/2025/aquatic-trial-quitting-versus-using-aspirin-therapy-patients-stabilized-cad-stenting-long-term-oral-anticoagulation/27448089-9-eng-GB/The-AQUATIC-trial-Assessment-of-quitting-versus-using-aspirin-therapy-in-patients-with-stabilized-coronary-artery-disease-after-stenting-who-requi_image_responsive_6.jpg)
NEO-MINDSET: Early withdrawal of aspirin after percutaneous coronary intervention for acute coronary syndrome
02 Sep 2025
Daniele Giacoppo reports and provides his perspective on the main results of the ambitious NEOMINDSET trial, presented by Pedro Lemos from the Hospital Israelita Albert Einstein, São Paulo, Brazil, during a Late Breaking Trials session at the ESC Congress 2025 in Madrid, and simultaneously published in the New...
Author
